Case-Based Learning: Integrating Findings From Multiple Specialties in a Complex Multisystem Presentation

Abstract

Case-based learning (CBL) has emerged as a pivotal strategy in medical education, especially when addressing complex multisystem presentations that necessitate the collaboration of multiple specialties. This article reviews the integration of diverse clinical findings, focusing on the mechanisms, epidemiology, diagnostic challenges, and management approaches in cases that cross specialty boundaries. It highlights the role of CBL in fostering interdisciplinary understanding, evidence-based practice, and improved patient outcomes, supported by recent literature and guideline recommendations.

Introduction

The complexity of multisystem diseases often demands the integration of knowledge from various specialties. Traditional didactic approaches may fall short in equipping healthcare professionals with the skills needed to synthesize and apply interdisciplinary information. Case-based learning (CBL) addresses this gap by presenting real-world clinical scenarios that require learners to analyze, discuss, and integrate findings across specialties. This approach not only enhances diagnostic acumen but also aligns with the modern paradigm of patient-centered and team-based care. The present review explores the scientific basis, clinical implications, and educational value of CBL in the context of complex multisystem presentations, underpinned by recent evidence and expert guidelines.

Epidemiology / Disease Burden

Multisystem presentations are increasingly recognized in a variety of clinical contexts, from systemic autoimmune diseases such as systemic lupus erythematosus (SLE) and sarcoidosis, to multisystem involvement in infections like COVID-19 and sepsis, to paraneoplastic syndromes and inherited metabolic disorders. Epidemiological data indicate that up to 25% of hospital admissions involve conditions that span more than one organ system. The burden is particularly high in aging populations and those with multiple comorbidities, leading to increased healthcare utilization, prolonged hospital stays, and higher morbidity and mortality rates. CBL, when applied to these scenarios, provides a framework for understanding the interplay between disease processes and the need for multidisciplinary intervention.

Pathophysiology

The pathophysiological complexity of multisystem presentations stems from overlapping mechanisms such as immune dysregulation, genetic predisposition, systemic inflammation, and vascular compromise. For example, in SLE, autoantibody formation leads to immune complex deposition across various organs, while in sepsis, a dysregulated host response results in widespread endothelial dysfunction and multi-organ failure. Understanding these mechanisms is crucial for accurate diagnosis and targeted therapy, and CBL scenarios often highlight these links, prompting learners to connect molecular events with clinical manifestations.

Risk Factors

Risk factors for multisystem presentations are multifaceted and include genetic predisposition (e.g., HLA haplotypes), environmental exposures, chronic infections, immunosuppression, and comorbid conditions such as diabetes or chronic kidney disease. Polypharmacy and the use of biologic agents have also contributed to the complexity of presentations seen in modern practice. CBL can be structured to emphasize identification and stratification of risk, facilitating early recognition and prevention strategies.

Clinical Features

Multisystem disease presentations are characterized by protean manifestations that can mimic or mask primary diagnoses. For instance, a patient with fever, fatigue, joint pain, and a rash may have an infectious, rheumatologic, or even neoplastic process. Emerging evidence shows that atypical presentations can delay diagnosis and adversely affect outcomes. CBL encourages learners to systematically approach symptoms, integrating findings such as laboratory results, imaging, and functional assessments to develop a comprehensive clinical picture. Emphasis is placed on red flags, syndromic patterns, and the value of multidisciplinary discussion in complex cases.

Diagnosis

Diagnostic evaluation of multisystem presentations involves a stepwise, hypothesis-driven approach, often requiring input from multiple specialties. Key steps include thorough history-taking, physical examination, targeted laboratory testing (e.g., autoantibodies, biomarkers), advanced imaging modalities (MRI, PET-CT), and sometimes tissue biopsy. CBL scenarios frequently focus on diagnostic dilemmas, underscoring the importance of ruling out life-threatening conditions, minimizing unnecessary interventions, and utilizing evidence-based algorithms. Recent advances in genomics, proteomics, and point-of-care diagnostics have further enhanced the diagnostic process, as reflected in contemporary CBL modules.

Treatment & Management

Management of complex multisystem cases requires tailored, interdisciplinary care plans. Therapeutic strategies may range from immunosuppressive and biologic agents in autoimmune diseases to antimicrobial therapy in systemic infections, alongside symptomatic and supportive measures. Coordination among specialties rheumatology, infectious disease, pulmonology, nephrology, and more is essential for optimizing outcomes. CBL reinforces the importance of communication, care transitions, and shared decision-making, providing practical frameworks for real-world application.

Recent Advances / Emerging Therapies

The landscape of multisystem disease management is rapidly evolving, with novel targeted therapies, personalized medicine approaches, and digital health tools transforming patient care. Advances include Janus kinase (JAK) inhibitors in systemic inflammation, monoclonal antibodies in rare autoimmune conditions, and telemedicine for multidisciplinary case conferences. CBL formats increasingly incorporate these innovations, exposing learners to cutting-edge therapies and their mechanisms, indications, and adverse effect profiles.

Guideline Recommendations

International guidelines now emphasize the integration of specialty expertise in managing complex multisystem presentations. Recommendations from bodies such as the American College of Rheumatology, Infectious Diseases Society of America, and European Society of Cardiology advocate for multidisciplinary team meetings, standardized care pathways, and early involvement of relevant specialties. CBL is strongly endorsed as an educational intervention to operationalize these guidelines, with evidence showing improvements in diagnostic accuracy, patient safety, and learner satisfaction.

Conclusion

Case-based learning stands as a cornerstone in the education and clinical management of complex multisystem presentations, facilitating the integration of diverse specialty knowledge and fostering a collaborative, evidence-based approach to care. By mirroring real-world challenges, CBL enhances diagnostic reasoning, interdisciplinary communication, and adherence to best practice guidelines, ultimately translating to superior patient outcomes. The continued evolution of CBL, informed by emerging scientific advances and robust educational research, will be instrumental in preparing clinicians for the complexities of modern healthcare.